Jan 8, 2024, 14:12
Combination immunotherapy in pleural mesothelioma – International Association for the Study of Lung Cancer
Quoting International Association for the Study of Lung Cancer on LinkedIn:
“Combination immunotherapy in pleural mesothelioma may not necessarily be less toxic for certain patients, according to real-world data published recently in the Journal of Thoracic Oncology. Learn more in ILCN.”
Source: International Association for the Study of Lung Cancer/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 19:25
Nov 13, 2024, 16:51
Nov 13, 2024, 16:49
Nov 13, 2024, 16:45
Nov 13, 2024, 16:25
Nov 13, 2024, 16:23
Nov 13, 2024, 16:08